Ei Itobayashi

机构：Asahi General Hospital · ORCID：0000-0003-0475-2819

发表论文 216 篇 · 总被引 3954 次 · h-index 36

代表论文

• Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin-Based Tumor Marker Score for First-Line Immunotherapy Selection in Hepatocellular Carcinoma (2025 · Liver Cancer · 被引 6)
• Efficacy and Safety of Atezolizumab Plus Bevacizumab Versus Durvalumab Plus Tremelimumab for Unresectable Hepatocellular Carcinoma in Patients With Child–Pugh Class B: A Real‐World Study (2026 · Hepatology Research · 被引 5)
• Real-World Comparison of First-Line Atezolizumab plus Bevacizumab and Durvalumab plus Tremelimumab for Unresectable Hepatocellular Carcinoma (2026 · Liver Cancer · 被引 3)
• Long-Term Effectiveness of Tenofovir Alafenamide Versus Entecavir in Treatment-Naive Chronic Hepatitis B: A Real-World Evidence from the Global Alliance for the Study of Hepatitis B Virus (2025 · The American Journal of Gastroenterology · 被引 3)
• Carbon-ion radiotherapy achieves outcomes equivalent to surgical resection for hepatocellular carcinoma (2025 · Hepatology Communications · 被引 3)
• Impact of metabolic dysfunction on treatment responses to nucleos(t)ide analogues in chronic hepatitis B: a retrospective multi-center REAL-B cohort study (2025 · EClinicalMedicine · 被引 3)